Delivery Order SPE2DB25D3404-SPE2DB25FUPBM
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through March 26, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 125 MG CAPSULE 21S medication. The $8,118.08 firm fixed-price contract has a completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This is a $16,244.96 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is a firm-fixed-price type, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a $16,236.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of IBRANCE 125MG CAP 21S, a specialty medication. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $8,118.08 and a period of performance through July 17, 2025. The contract is designated as a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a medication, with a total ceiling value of $8,118.08 and a completion date of June 12, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of 4563753747 IBRANCE 125 MG CAPSULE 21S, with a potential value of $7,792.08 and a completion date of March 15, 2024. This delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $7,792.08 and is a firm-fixed price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,118.08, is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. The contract is a firm fixed-price delivery order with a performance period ending on May 21, 2025. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,118.08 firm fixed-price contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a medication, with a period of performance through July 16, 2025. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPBMDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,118.08, is for the delivery of 4568689627 ! IBRANCE 125 MG CAPSULE 21S, with a completion date of July 23, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 7/1/25 |